BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29899868)

  • 1. Distinct age-associated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profiling.
    Tarlock K; Zhong S; He Y; Ries R; Severson E; Bailey M; Morley S; Balasubramanian S; Erlich R; Lipson D; Otto GA; Vergillo JA; Kolb EA; Ross JS; Mughal T; Stephens PJ; Miller V; Meshinchi S; He J
    Oncotarget; 2018 May; 9(41):26417-26430. PubMed ID: 29899868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia.
    Balgobind BV; Lugthart S; Hollink IH; Arentsen-Peters ST; van Wering ER; de Graaf SS; Reinhardt D; Creutzig U; Kaspers GJ; de Bont ES; Stary J; Trka J; Zimmermann M; Beverloo HB; Pieters R; Delwel R; Zwaan CM; van den Heuvel-Eibrink MM
    Leukemia; 2010 May; 24(5):942-9. PubMed ID: 20357826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
    Au CH; Wa A; Ho DN; Chan TL; Ma ES
    Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling.
    Wang M; Lindberg J; Klevebring D; Nilsson C; Mer AS; Rantalainen M; Lehmann S; Grönberg H
    Leukemia; 2017 Oct; 31(10):2029-2036. PubMed ID: 28167833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Mutations as Emerging Biomarkers and Therapeutic Targets for Relapsed Acute Myeloid Leukemia.
    Aziz H; Ping CY; Alias H; Ab Mutalib NS; Jamal R
    Front Pharmacol; 2017; 8():897. PubMed ID: 29270125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
    J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has gene expression profiling improved diagnosis, classification, and outcome prediction in AML?
    Willman CL
    Best Pract Res Clin Haematol; 2008 Mar; 21(1):21-8. PubMed ID: 18342809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
    Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parallel targeted next generation sequencing of childhood and adult acute myeloid leukemia patients reveals uniform genomic profile of the disease.
    Marjanovic I; Kostic J; Stanic B; Pejanovic N; Lucic B; Karan-Djurasevic T; Janic D; Dokmanovic L; Jankovic S; Vukovic NS; Tomin D; Perisic O; Rakocevic G; Popovic M; Pavlovic S; Tosic N
    Tumour Biol; 2016 Oct; 37(10):13391-13401. PubMed ID: 27460089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of
    Tan M; Ng IKS; Chen Z; Ban K; Ng C; Chiu L; Seah E; Lin M; Tai BC; Yan B; Ng CH; Chng WJ
    J Clin Pathol; 2017 Aug; 70(8):669-676. PubMed ID: 28100593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.
    Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Fu B; Tang G; Goswami M; Singh R; Kanagal-Shamanna R; Pierce SA; Young KH; Kantarjian HM; Medeiros LJ; Luthra R; Wang SA
    Leuk Res; 2015 Mar; 39(3):348-54. PubMed ID: 25573287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of pediatric acute myeloid leukemia based on miRNA expression profiles.
    Obulkasim A; Katsman-Kuipers JE; Verboon L; Sanders M; Touw I; Jongen-Lavrencic M; Pieters R; Klusmann JH; Michel Zwaan C; van den Heuvel-Eibrink MM; Fornerod M
    Oncotarget; 2017 May; 8(20):33078-33085. PubMed ID: 28380436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infant Acute Myeloid Leukemia: A Unique Clinical and Biological Entity.
    Calvo C; Fenneteau O; Leverger G; Petit A; Baruchel A; Méchinaud F
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33668444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia.
    Patel JL; Schumacher JA; Frizzell K; Sorrells S; Shen W; Clayton A; Jattani R; Kelley TW
    Leuk Res; 2017 May; 56():7-12. PubMed ID: 28152414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated genomic profiling, therapy response, and survival in adult acute myelogenous leukemia.
    Parkin B; Ouillette P; Yildiz M; Saiya-Cork K; Shedden K; Malek SN
    Clin Cancer Res; 2015 May; 21(9):2045-56. PubMed ID: 25652455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group study.
    Kuerbitz SJ; Civin CI; Krischer JP; Ravindranath Y; Steuber CP; Weinstein HJ; Winick N; Ragab AH; Gresik MV; Crist WM
    J Clin Oncol; 1992 Sep; 10(9):1419-29. PubMed ID: 1517785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complex karyotype abnormalities in pediatric acute myeloid leukemia].
    Fleĭshman EV; Sokova OI; Kirichenko OP; Konstantinova LN; Metel'kova NF; Popa AV; Shneĭder MM
    Vestn Ross Akad Med Nauk; 2008; (5):3-7. PubMed ID: 18589906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification of novel pathogenic gene mutations in pediatric acute myeloid leukemia by whole-exome resequencing].
    Shiba N
    Rinsho Ketsueki; 2015 Dec; 56(12):2419-25. PubMed ID: 26725349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group.
    Matsuo H; Nakamura N; Tomizawa D; Saito AM; Kiyokawa N; Horibe K; Nishinaka-Arai Y; Tokumasu M; Itoh H; Kamikubo Y; Nakayama H; Kinoshita A; Taga T; Tawa A; Taki T; Tanaka S; Adachi S
    Pediatr Blood Cancer; 2016 Aug; 63(8):1394-9. PubMed ID: 27135782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low efficacy of methotrexate in childhood acute myeloid leukemia (AML): single-agent therapeutic window study in relapsed AML.
    Kaspers GJ; Reinhardt D; Fleischhack G; Armendariz H; Stark B; Zwaan CM; Zimmermann M; Creutzig U
    Pediatr Blood Cancer; 2006 Oct; 47(5):539-42. PubMed ID: 16358301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.